Importin 3D structures
From Proteopedia
(Difference between revisions)
Line 45: | Line 45: | ||
*''IPO-α 1 complex with NLS peptide'' | *''IPO-α 1 complex with NLS peptide'' | ||
- | **[[4b18]] – hIPO NLS-binding domain + telomerase reverse transcriptase<br /> | + | **[[2jdq]], [[4b18]] – hIPO NLS-binding domain + telomerase reverse transcriptase<br /> |
**[[4wv6]] – hIPO NLS-binding domain + TFIID<br /> | **[[4wv6]] – hIPO NLS-binding domain + TFIID<br /> | ||
**[[6bw0]] – hIPO NLS-binding domain + Nipa virus peptide<br /> | **[[6bw0]] – hIPO NLS-binding domain + Nipa virus peptide<br /> | ||
Line 55: | Line 55: | ||
**[[7n8j]] – hIPO NLS-binding domain + BIMAX peptide<br /> | **[[7n8j]] – hIPO NLS-binding domain + BIMAX peptide<br /> | ||
**[[5h43]] – hIPO NLS-binding domain + histone acetyltransferase KAT8<br /> | **[[5h43]] – hIPO NLS-binding domain + histone acetyltransferase KAT8<br /> | ||
+ | **[[8gcn]] – hIPO NLS-binding domain + IPO-beta 1 peptide – Cryo EM<br /> | ||
**[[8gai]] – IPO NLS-binding domain + BIMAX peptide – guinea pig<br /> | **[[8gai]] – IPO NLS-binding domain + BIMAX peptide – guinea pig<br /> | ||
**[[4mz5]], [[4mz6]] – mIPO NLS-binding domain 70-528 + dUTPase<br /> | **[[4mz5]], [[4mz6]] – mIPO NLS-binding domain 70-528 + dUTPase<br /> | ||
Line 90: | Line 91: | ||
**[[7rg4]], [[7rg5]] – mIPO NLS-binding domain + p50 peptide <br /> | **[[7rg4]], [[7rg5]] – mIPO NLS-binding domain + p50 peptide <br /> | ||
**[[6wx7]] – mIPO NLS-binding domain + SOX2 peptide <br /> | **[[6wx7]] – mIPO NLS-binding domain + SOX2 peptide <br /> | ||
+ | **[[8g8q]] – mIPO NLS-binding domain + monopartite p52 NLS + peptide<br /> | ||
+ | **[[8g8s]] – mIPO NLS-binding domain + bipartite p52 NLS peptide<br /> | ||
+ | **[[9cl8]], [[9cle]], [[9clf]], [[9clg]] – mIPO NLS-binding domain + zero net charge NLS peptide<br /> | ||
+ | **[[9y0r]] – mIPO NLS-binding domain + ATF2 peptide<br /> | ||
+ | **[[5fc8]], [[5hhg]], [[8vpr]], [[8vpu]] – mIPO NLS-binding domain + dengue virus peptide<br /> | ||
**[[4b8o]] – rIPO NLS-binding domain + SV40<br /> | **[[4b8o]] – rIPO NLS-binding domain + SV40<br /> | ||
**[[4b8p]] – rIPO NLS-binding domain + A89<br /> | **[[4b8p]] – rIPO NLS-binding domain + A89<br /> | ||
Line 101: | Line 107: | ||
**[[2jdq]] – hIPO NLS-binding domain + telomerase reverse transcriptase peptide<br /> | **[[2jdq]] – hIPO NLS-binding domain + telomerase reverse transcriptase peptide<br /> | ||
**[[4uaf]] – mIPO NLS-binding domain + influenza RNA polymerase<br /> | **[[4uaf]] – mIPO NLS-binding domain + influenza RNA polymerase<br /> | ||
+ | **[[8sg7]], [[9cft]] – mIPO NLS-binding domain + adeno-associated virus VP1<br /> | ||
*IPO-α 2 | *IPO-α 2 | ||
Line 126: | Line 133: | ||
**[[3ve6]] – mIPO NLS-binding domain + Venezuelan equine encephalitis virus<br /> | **[[3ve6]] – mIPO NLS-binding domain + Venezuelan equine encephalitis virus<br /> | ||
**[[8f2q]] – mIPO NLS-binding domain + parvovirus<br /> | **[[8f2q]] – mIPO NLS-binding domain + parvovirus<br /> | ||
+ | **[[8q8k]], [[8sud]], [[8tuq]], [[8tur]], [[8tus]], [[8tut]], [[8tuu]], [[8tuv]] – mIPO NLS-binding domain + polyomavirus peptide<br /> | ||
+ | **[[8sv0]], [[8u36]] – mIPO NLS-binding domain + siadenovirus peptide<br /> | ||
+ | **[[8g8r]] – mIPO NLS-binding domain + RELB peptide<br /> | ||
**[[3uvu]] – mIPO NLS-binding domain + flap endonuclease<br /> | **[[3uvu]] – mIPO NLS-binding domain + flap endonuclease<br /> | ||
**[[3ukw]], [[3ukx]] – mIPO NLS-binding domain + BIMAX<br /> | **[[3ukw]], [[3ukx]] – mIPO NLS-binding domain + BIMAX<br /> | ||
Line 145: | Line 155: | ||
**[[6bvz]] – hIPO NLS-binding domain <br /> | **[[6bvz]] – hIPO NLS-binding domain <br /> | ||
**[[4uae]] – hIPO NLS-binding domain + influenza RNA polymerase<br /> | **[[4uae]] – hIPO NLS-binding domain + influenza RNA polymerase<br /> | ||
+ | **[[8qxx]] – hIPO NLS-binding domain + Herpes DNA polymerase processivity factor peptide<br /> | ||
+ | **[[8qxw]] – hIPO NLS-binding domain + cytomegalovirus DNA polymerase processivity factor peptide<br /> | ||
**[[6bw9]], [[6bwa]], [[6bwb]] – hIPO NLS-binding domain + Hendra virus peptide<br /> | **[[6bw9]], [[6bwa]], [[6bwb]] – hIPO NLS-binding domain + Hendra virus peptide<br /> | ||
**[[6bvv]] – hIPO NLS-binding domain + Nipa virus peptide<br /> | **[[6bvv]] – hIPO NLS-binding domain + Nipa virus peptide<br /> | ||
Line 186: | Line 198: | ||
**[[1ibr]] – hIPO + GTPase Ran<br /> | **[[1ibr]] – hIPO + GTPase Ran<br /> | ||
**[[6n88]], [[6n89]] – hIPO + H1.0 – Cryo EM<br /> | **[[6n88]], [[6n89]] – hIPO + H1.0 – Cryo EM<br /> | ||
+ | **[[9b4y]] – hIPO + IPO beta 1 peptide – Cryo EM<br /> | ||
**[[1f59]], [[1o6p]], [[1o6o]] – hIPO + FXFG nucleoporin repeats<br /> | **[[1f59]], [[1o6p]], [[1o6o]] – hIPO + FXFG nucleoporin repeats<br /> | ||
**[[1m5n]] – hIPO HEAT repeats 1-11 + parathyroid hormone-related protein NLS peptide<br /> | **[[1m5n]] – hIPO HEAT repeats 1-11 + parathyroid hormone-related protein NLS peptide<br /> | ||
Line 209: | Line 222: | ||
**[[5tqc]] – hIPO + RPL4 peptide<br /> | **[[5tqc]] – hIPO + RPL4 peptide<br /> | ||
**[[5j3v]] – hIPO + histone H3 peptide<br /> | **[[5j3v]] – hIPO + histone H3 peptide<br /> | ||
+ | **[[8sgh]] – hIPO NLS-binding domain + HNRNPH2 <br /> | ||
*IPO-β 3 (Karyopherin β 3) | *IPO-β 3 (Karyopherin β 3) | ||
Line 224: | Line 238: | ||
**[[6aho]] – yIPO <br /> | **[[6aho]] – yIPO <br /> | ||
+ | **[[8h5b]] – yIPO + TATA box – Cryo EM<br /> | ||
+ | **[[8f0x]] – yIPO + histone H2A.2 + H2B.2 – Cryo EM<br /> | ||
+ | **[[8f19]] – yIPO + RANGTP – Cryo EM<br /> | ||
*IPO-4 | *IPO-4 | ||
Line 238: | Line 255: | ||
**[[6xte]], [[6xu2]] – hIPO + antipain peptide <br /> | **[[6xte]], [[6xu2]] – hIPO + antipain peptide <br /> | ||
+ | **[[9im6]] – mIPO NLS-binding domain + RanBP5 peptide – Cryo EM<br /> | ||
*IPO-7 | *IPO-7 | ||
Line 246: | Line 264: | ||
**[[6n1z]] – hIPO + histone H2A + histone H2B <br /> | **[[6n1z]] – hIPO + histone H2A + histone H2B <br /> | ||
+ | **[[8f7a]] – hIPO NLS-binding domain + RanGTP – Cryo EM<br /> | ||
*IPO-12 (Transportin-3) | *IPO-12 (Transportin-3) | ||
Line 253: | Line 272: | ||
**[[4c0q]], [[4ol0]] – hIPO + GTPase Ran<br /> | **[[4c0q]], [[4ol0]] – hIPO + GTPase Ran<br /> | ||
**[[6gx9]] – hIPO + CPSF 68<br /> | **[[6gx9]] – hIPO + CPSF 68<br /> | ||
+ | **[[8cmk]] – hIPO + CIRBP<br /> | ||
*IPO-13 (karyopherin 13) | *IPO-13 (karyopherin 13) |
Current revision
3D structures of importin
Updated on 18-September-2025